Recon: UK launches trial of Grail blood test for 50 types of cancer; AbbVie hands Regenxbio $370M to develop gene therapy
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy